The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 74 Years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: MRI scans, Interviews, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women."
- "The primary outcome is informed decisions about breast MRI at T1."
- "The aim of this study is to evaluate whether the decision support intervention produces a clinically significant change in informed decisions about breast MRI."
- "The main hypothesis is that participants receiving the decision support intervention will be more likely to make an informed decision about breast MRI v. participants receiving enhanced usual care."
- "During intake interviews for new RLC patients, navigators will administer the NCI Breast Cancer Risk Assessment Tool (BCRAT) via phone, enter responses into the BCRAT website in real-time, calculate lifetime breast cancer risk, and document BCRAT results in RLC's HIPAA-compliant, web-based patient tracking platform (RIPPLE©)."
- "The BCRAT provides estimated lifetime risk for breast cancer to inform use of breast MRI, and will be used to determine study eligibility."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether a decision aid helps Black and Latina women at high risk for breast cancer make informed choices about breast MRI, a scan that takes pictures of the breast. Women will be assigned by chance to get a risk check and referral to a nurse practitioner, either with or without the decision aid. Researchers will check their decisions after 1 month.
The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Female and 18–74 years old.
- Identify as Black, Latina, or both.
- Have never had breast cancer.
- Speak English or Spanish.
- Had a normal mammogram (breast X-ray) in the past 12 months.
- Have at least a 20% lifetime chance of breast cancer, based on the NCI Breast Cancer Risk Assessment Tool.
Who can't join
- Younger than 18 or age 75 or older.
- Pregnant.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * female * aged 18-74 years * self-identifying as Black and/or Latina * no personal history of breast cancer * English- or Spanish-speaking * having received a mammogram with normal results in the last 12 months * ≥20% lifetime breast cancer risk per the NCI Breast Cancer Risk Assessment Tool (BCRAT) Exclusion Criteria: * aged \<18 or ≥75 * pregnancy
Study sites (1)
DC
- Georgetown University · Washington D.C., DC 20007Claire C. Conley, PhD · Study contact · 202-687-5086 · claire.conley@georgetown.eduClaire C. Conley, PhD · Principal investigatorMore trials in Washington D.C.